← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
National Center For Advancing Translational Sciences
$2,441,471
Total funding
4
Grants
Funding over time
peak $213.4M · FY2012–25$250M$187.5M$125M$62.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,441,471 · 4
By mechanism
Y01$2,441,471 · 4
Investigators at National Center For Advancing Translational Sciences
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Antiviral Program for Pandemics (APP) & NCATS: Accelerating Antiviral Development$77,500,000
ZIA · FY2022 · TR
Antiviral Program for Pandemics (APP) & NCATS: Accelerating Antiviral Development$34,357,967
ZIA · FY2023 · TR
Preclinical Innovation$30,713,573
ZIB · FY2014 · TR
Therapeutics for Rare and Neglected Diseases - Science$23,954,749
ZIB · FY2012 · TR
Therapeutics for Rare and Neglected Diseases - Science$22,576,918
ZIB · FY2013 · TR
Molecular Libraries Probe Production Centers Network$22,385,405
ZIB · FY2014 · TR
NIH Chemical Genomics Center$15,437,118
ZIB · FY2012 · TR
NIH Chemical Genomics Center$14,448,955
ZIB · FY2013 · TR
Research Services Core (RSC)$10,999,069
ZIC · FY2021 · TR
Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose$10,316,802
ZIA · FY2022 · TR
HEAL: Development of Clinical Candidate Drugs for Pain, Addiction and Overdose$10,299,226
ZIA · FY2020 · TR
Research Services Core (RSC)$10,097,450
ZIC · FY2020 · TR
HEAL: Development of Clinical Candidate Drugs for Pain, Addiction and Overdose$9,587,227
ZIA · FY2019 · TR
Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose$9,556,745
ZIA · FY2021 · TR
Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose$8,627,631
ZIA · FY2023 · TR
Research Services Core (RSC)$8,364,044
ZIC · FY2019 · TR
Research Services Core (RSC)$8,012,895
ZIC · FY2025 · TR
HEAL: Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose$7,703,354
ZIA · FY2019 · TR
Development of A Specialized Platform for Innovative Research Exploration (ASPIRE)$7,543,211
ZIC · FY2024 · TR
Stem Cell Translation Laboratory (SCTL)$7,000,000
ZIA · FY2019 · TR